1. Home
  2. CASH vs NNNN Comparison

CASH vs NNNN Comparison

Compare CASH & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pathward Financial Inc.

CASH

Pathward Financial Inc.

HOLD

Current Price

$76.48

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$40.55

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CASH
NNNN
Founded
1954
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
CASH
NNNN
Price
$76.48
$40.55
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$91.00
N/A
AVG Volume (30 Days)
219.1K
37.0K
Earning Date
01-22-2026
04-28-2026
Dividend Yield
0.27%
N/A
EPS Growth
9.29
N/A
EPS
7.87
0.06
Revenue
$780,120,000.00
$6,920,153.00
Revenue This Year
$10.95
N/A
Revenue Next Year
$4.75
N/A
P/E Ratio
$9.50
$668.91
Revenue Growth
5.66
N/A
52 Week Low
$64.45
$5.18
52 Week High
$86.00
$55.65

Technical Indicators

Market Signals
Indicator
CASH
NNNN
Relative Strength Index (RSI) 61.03 N/A
Support Level $73.08 N/A
Resistance Level $75.48 N/A
Average True Range (ATR) 1.67 0.00
MACD 0.14 0.00
Stochastic Oscillator 95.42 0.00

Price Performance

Historical Comparison
CASH
NNNN

About CASH Pathward Financial Inc.

Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: